Quarterly report pursuant to Section 13 or 15(d)


SUBSEQUENT EVENTS (Details Textual) - USD ($)
1 Months Ended
Nov. 14, 2018
Oct. 29, 2018
Feb. 13, 2015
Subsequent Event [Line Items]      
Stockholders' Equity, Reverse Stock Split     the Company implemented a 1-for-0.831105 reverse stock split of the common stock, which had previously been approved on September 24, 2014.
Subsequent Event [Member]      
Subsequent Event [Line Items]      
Debt Instrument, Interest Rate, Stated Percentage 1.00%    
Convertible Notes Payable $ 2,750,000    
Debt Instrument, Convertible, Terms of Conversion Feature 20% discount on a 30 day VWAP of the Company's stock price if more than $2,000,000 is raised in equity financing or matures on March 28, 2019.    
Stockholders' Equity, Reverse Stock Split   the Company effected a reverse stock split and thereafter Bionik's common stock began trading on the OTCQB market on a one-for-one hundred and fifty (1:150) split adjusted basis.